Biorest Ltd.
Records under this name other than patents Biorest Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,943,481 | Compositions and methods using same for delivering agents into a target organ protected by a blood barrier Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,265,269 | Liposome Formulation and Manufacture Formerly held In force · Low confidence | In force | Low confidence | |
| US 11,633,357 | Liposome Formulation and Manufacture Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,993,427 | Liposome formulation and manufacture Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,722,463 | Compositions and methods using same for delivering agents into a target organ protected by a blood barrier Formerly held In force Term ended Sep 23, 2026 · From the USPTO record | In force | Term ended Sep 23, 2026 | From the USPTO record |
| US 10,517,883 | Method of treating acute myocardial infarction Formerly held Lapsed on the fee record Ended Dec 31, 2023 · From the USPTO record | Lapsed on the fee record | Ended Dec 31, 2023 | From the USPTO record |
| US 10,213,446 | Method of treating acute coronary syndromes Formerly held Lapsed on the fee record Ended Feb 26, 2023 · From the USPTO record | Lapsed on the fee record | Ended Feb 26, 2023 | From the USPTO record |
| US 7,048,714 | Drug eluting medical device with an expandable portion for drug release Formerly held Term ended Term ended Oct 30, 2022 · From the USPTO record | Term ended | Term ended Oct 30, 2022 | From the USPTO record |
| US 9,827,254 | Method of treating acute coronary syndromes Formerly held Lapsed on the fee record Ended Nov 28, 2021 · From the USPTO record | Lapsed on the fee record | Ended Nov 28, 2021 | From the USPTO record |
| US 9,820,998 | Use of Bisphosphonates as HIV/Aids Adjunctive Treatment Formerly held Lapsed on the fee record Ended Nov 21, 2021 · High confidence | Lapsed on the fee record | Ended Nov 21, 2021 | High confidence |